Inventor · disambiguated record
Francis Gosselin
Also filed as: GOSSELIN FRANCIS
40 granted patents·17 pending applications·173 citations·filing 1990–2024
97Inventor score
Top patents by PatentIndex Score
57 records- 0195US10772874B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2019·Granted Sep 15, 2020·6 cites·11 claims
- 0293US10272072B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2016·Granted Apr 30, 2019·11 cites·19 claims
- 0393US9458172B2Pyridinyl and pyrimidinyl sulfoxide and sulfone derivativesBAIR KENNETH W·Filed 2013·Granted Oct 4, 2016·25 cites·20 claims
- 0491US11547701B2Compounds and compositions for the inhibition of NAMPTVALO HEALTH INC·Filed 2020·Granted Jan 10, 2023·2 cites·11 claims
- 0591US10456382B2Compounds and compositions for the inhibition of NAMPTFORMA TM LLC·Filed 2018·Granted Oct 29, 2019·7 cites·20 claims
- 0691US9315471B2Process of making hydroxylated cyclopentapyrimidine compounds and salts thereofGENENTECH INC·Filed 2013·Granted Apr 19, 2016·12 cites·16 claims
- 0789US10781219B2Process for the preparation of (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[F]imidazo[1,2-D][1,4]oxazepin-9-yl)amino) propanamideGENENTECH INC·Filed 2019·Granted Sep 22, 2020·5 cites·20 claims
- 0889US10385058B2Process for preparing BTK inhibitorsGENENTECH INC·Filed 2017·Granted Aug 20, 2019·3 cites·54 claims
- 0988US10882864B2Process for preparing BTK inhibitorsGENENTECH INC·Filed 2019·Granted Jan 5, 2021·3 cites·24 claims
- 1087US10954234B2Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3- fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their useGENENTECH INC·Filed 2019·Granted Mar 23, 2021·6 cites·81 claims
- 1186US11969426B2Pharmaceutical compositions comprising Akt protein kinase inhibitorsGENENTECH INC·Filed 2022·Granted Apr 30, 2024·1 cites·20 claims
- 1286US9290458B2Amorphous form of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereofGENENTECH INC·Filed 2013·Granted Mar 22, 2016·4 cites·44 claims
- 1384US11661424B2Process for preparing BTK inhibitorsGENENTECH INC·Filed 2020·Granted May 30, 2023·1 cites·11 claims
- 1484US5069714ASegregation-free metallurgical powder blends using polyvinyl pyrrolidone binderQUEBEC METAL POWDERS LTD·Filed 1990·Granted Dec 3, 1991·56 cites·34 claims
- 1583US12336981B2Compounds and compositions for the inhibition of NAMPTVALO HEALTH INC·Filed 2022·Granted Jun 24, 2025·0 cites·11 claims
- 1683US11337977B2Pharmaceutical compositions comprising Akt protein kinase inhibitorsGENENTECH INC·Filed 2017·Granted May 24, 2022·3 cites·12 claims
- 1782US9862689B2Processes for the preparation of pyrimidinylcyclopentane compoundsGENENTECH INC·Filed 2014·Granted Jan 9, 2018·4 cites·27 claims
- 1882US9505725B2Crystalline and mesomorphous forms of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereofGENENTECH INC·Filed 2016·Granted Nov 29, 2016·2 cites·17 claims
- 1982US7915298B2Compounds and methods for leukotriene biosynthesis inhibitionMERCK SHARP & DOHME·Filed 2008·Granted Mar 29, 2011·8 cites·6 claims
- 2081US10696692B2Amido-benzyl sulfone and sulfoxide derivatesFORMA TM LLC·Filed 2013·Granted Jun 30, 2020·6 cites·4 claims
- 2181US10435378B2Processes for the preparation of pyrimidinylcyclopentane compoundsGENENTECH INC·Filed 2017·Granted Oct 8, 2019·2 cites·33 claims
- 2281US9441228B2Post-synthetic chemical modification of RNA at the 2′-position of the ribose ring via “click” chemistrySIRNA THERAPEUTICS INC·Filed 2015·Granted Sep 13, 2016·2 cites·18 claims
- 2380US12440492B2Pharmaceutical compositions comprising AKT protein kinase inhibitorsGENENTECH INC·Filed 2024·Granted Oct 14, 2025·0 cites·17 claims
- 2480US8895729B2Process for making thienopyrimidine compoundsGENENTECH INC·Filed 2013·Granted Nov 25, 2014·3 cites·15 claims
- 2580US2024409535A1Solid forms of 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2h-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their useGENENTECH INC·Filed 2024·Application pending·0 cites
- 2678US2024317738A1Solid forms of 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2h-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their useGENENTECH INC·Filed 2023·Application pending·0 cites
- 2778US2023250103A1Process for preparing btk inhibitorsGENENTECH INC·Filed 2023·Application pending·0 cites
- 2872US2025059155A1Process for synthesis of quinazoline compoundsGENENTECH INC·Filed 2024·Application pending·0 cites
- 2971US10457648B2Process for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compoundsHOFFMANN LA ROCHE·Filed 2015·Granted Oct 29, 2019·1 cites·14 claims
- 3070US10858324B2Processes for the preparation of pyrimidinylcyclopentane compoundsGENENTECH INC·Filed 2019·Granted Dec 8, 2020·0 cites·12 claims
- 3169US2025051351A1Synthesis of a bis-mesylate salt of 4-amino-n-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide and intermediates theretoGENENTECH INC·Filed 2024·Application pending·0 cites
- 3269US2025074893A1Synthesis of quinazoline compoundsGENENTECH INC·Filed 2024·Application pending·0 cites
- 3368US11780834B2Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3- yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their useHOFFMANN LA ROCHE·Filed 2020·Granted Oct 10, 2023·0 cites·72 claims
- 3468US10870626B2Process for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compoundsHOFFMANN LA ROCHE·Filed 2019·Granted Dec 22, 2020·0 cites·8 claims
- 3567US11999749B2Synthesis of a bis-mesylate salt of 4-amino-N-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide and intermediates theretoGENENTECH INC·Filed 2022·Granted Jun 4, 2024·0 cites·13 claims
- 3666US11136330B2Synthesis of labeled imidazo[1,2-A]pyrimidinesGENENTECH INC·Filed 2020·Granted Oct 5, 2021·0 cites·38 claims
- 3763US2024166595A1Process for the preparation of benzoxazepin oxazolidinone compoundsGENENTECH INC·Filed 2023·Application pending·0 cites
- 3862US12071422B2Process for synthesis of quinazoline compoundsGENENTECH INC·Filed 2023·Granted Aug 27, 2024·0 cites·48 claims
- 3962US2024294464A1Synthesis of restrained complexing agentsGENENTECH INC·Filed 2024·Application pending·0 cites
- 4060US2025059147A1Processes for the preparation of phenyltetrahydrofuran compoundsGENENTECH INC·Filed 2024·Application pending·0 cites
- 4160US2024034739A1Processes for making bicyclic ketone compoundsGENENTECH INC·Filed 2023·Application pending·0 cites
- 4259US11702452B2Process for making arylomycin ring analogsGENENTECH INC·Filed 2021·Granted Jul 18, 2023·0 cites·8 claims
- 4358US12172982B2Synthesis of quinazoline compoundsGENENTECH INC·Filed 2021·Granted Dec 24, 2024·0 cites·52 claims
- 4458US2014294805A1Novel compounds and compositions for the inhibition of namptBAIR KENNETH W·Filed 2011·Application pending·0 cites
- 4558US2017137815A1Novel single chemical entities and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4657US11325912B2Regio-selective synthesis of imidazo[1,2-a]pyrimidinesGENENTECH INC·Filed 2020·Granted May 10, 2022·0 cites·8 claims
- 4755US2016074525A1Novel single chemical entities and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4855US2016348109A1Post-synthetic chemical modification of rna at the 2'-position of the ribose ring via "click" chemistrySIRNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4954US11192924B2Process for making arylomycin ring analogsGENENTECH INC·Filed 2019·Granted Dec 7, 2021·0 cites·11 claims
- 5054US2013253168A1Novel single chemical entities and methods for delivery of oligonucleotidesCOLLETTI STEVEN L·Filed 2011·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Francis Gosselin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →